Results indicate preservation of sexual function<\/p>\n<\/h3>\n
By Lori Solomon HealthDay Reporter<\/b>
\n<\/b><\/p>\n
TUESDAY, April 8, 2025 (HealthDay News) — Blue laser vaporization alleviates lower urinary tract symptoms while preserving sexual function in patients undergoing benign prostatic hyperplasia (BPH) surgery, according to a study published online March 4 in The Aging Male<\/em>.<\/p>\n Zun-Jie Hu, from The Affiliated Taian City Central Hospital of Qingdao University in China, and colleagues assessed the impact of 450-nm blue laser vaporization on sexual function in 67 patients (median age, 65 years) undergoing BPH surgery and followed for three months.<\/p>\n The researchers found that blue laser vaporization significantly improved International Prostate Symptom Score, quality of life, and International Consultation on Incontinence Modular Questionnaire for Male Lower Urinary Tract Symptoms (ICIQ-MLUTS) scores. Blue laser vaporization was also significantly associated with a reduction in postvoid residual volume. There were no significant changes seen in the International Index of Erectile Function 5 score, Male Sexual Health Questionnaire for Ejaculatory Dysfunction score, or ICIQ-MLUTS sex score, demonstrating preservation of sexual function after surgery.<\/p>\n “To determine the longevity of these effects, additional clinical data and extended follow-up periods are necessary,” the authors write. “The findings present an effective surgical approach for safeguarding sexual function in BPH patients.”<\/p>\n